Salience Learning’s Post

Outlook Business highlights 23 impactful changemakers of 2023, recognizing those making a lasting difference beyond social media trends. Delighted to announce that Akums has been recognized in Outlook Business as one of the distinguished Pharma Change Makers who have truly shaped the landscape of 2023. As Change Makers, Akums embodies the spirit of innovation, resilience, and progressive impact. With a commitment to innovation, excellence, and transformative impact, Akums stands as a beacon of change in the pharmaceutical industry. For more, read the article: https://lnkd.in/gvEEy6kQ #Akums #PharmaIndustry #contractmanufacturing #pharmaceuticals #akumsstrength #innovation #manufacturing #quality #pharmaceuticalindustry

Discover Key Industry Trends at Pharma Europe 2024! Pharma Europe 2024 is your ultimate gateway to the most significant trends shaping the #pharmaceutical_industry. Join us in Frankfurt, Germany, on July 25-26, 2024, for an event that will offer you exceptional insights and a glimpse into the future of #pharma. Here’s why this is an unmissable opportunity. Importance: •            Expand Your Network •            Drive Strategic Decisions •            Enhance Your Expertise •            Stay Ahead of the Curve #PharmaEurope2024 #CareerAdvancement #IndustryExperts #ProfessionalDevelopment #NetworkingOpportunities #IndustryInsights #SuccessStories

💡 Join Syneos Health for an informative webinar focused on strategies and insights needed to comply with the Inflation Reduction Act (IRA) and capitalize on its new provisions for drug development, pricing, and market access in the biopharmaceutical industry. Attendees will: ✅ Learn new compliance requirements and regulatory adjustments ✅ Explore the IRA's impact on drug development, pricing, and market access ✅ Discover strategic planning techniques to drive innovation while maintaining compliance 📌 Learn more + register here: https://buff.ly/3xRHhR8 🌟 Featured speakers: Tiffany M. Peter Yixiao Zou, Ph.D. #DrugDevelopment #PharmaceuticalManufacturing #Commercialization #HEOR #MarketAccess

Interested in learning more about virtual control groups? Join us for a webinar and discussion. Be the first to open the door to Virtual Control Group (VCG) insights within the #biotechnology and #pharmaceutical industry. Join Laura Lotfi on July 18 for a live webinar, Unlock Hidden Insights: Virtual Control Groups as a Data-Driven Novel Method, where she will discuss the practical and regulatory steps for implementing VCGs into future nonclinical studies. https://okt.to/QKLPhm

Outlook Business highlights 23 impactful changemakers of 2023, recognizing those making a lasting difference beyond social media trends. Delighted to announce that Akums has been recognized in Outlook Business as one of the distinguished Pharma Change Makers who have truly shaped the landscape of 2023. As Change Makers, Akums embodies the spirit of innovation, resilience, and progressive impact. With a commitment to innovation, excellence, and transformative impact, Akums stands as a beacon of change in the pharmaceutical industry. For more, read the article: https://lnkd.in/gNAWeuMT #Akums #PharmaIndustry #contractmanufacturing #pharmaceuticals #akumsstrength #innovation #manufacturing #quality #pharmaceuticalindustry

🚨 Join me at Biopharma 2024: Navigating the Patent Cliff - Opportunities and Challenges! 🚨 Looking forward to speaking at Philadelphia Alliance for Capital and Technologies (PACT) Life Sciences roundtable on October 9, 2024, from 8:30 AM - 10:30 AM! I’ll be sharing insights on how AI is transforming the pharmaceutical landscape, especially as we face the critical moment of blockbuster drug patent expirations. 💡 We'll explore: The rapidly changing landscape in the pharmaceutical industry as a multitude of blockbuster drugs approach their patent expiration. The role of AI and AI-driven strategies play a role and can uncover opportunities amid industry shifts. The national and local impact on biopharma, with a focus on the Philadelphia market I’ll be joined by some fantastic panelists: Matthew Fedowitz, Shareholder, Life Sciences, Buchanan Ingersoll & Rooney PC Brian Winne, CPA, Senior Analyst, RSM US LLP Tom Evegan, Principal, Strategy & Management Consulting, RSM (Moderator) A big thank you to RSM for sponsoring this important discussion! 🌟 Looking forward to sharing how AI can shape the future of biopharma with you all! #Biopharma2024 #AIinPharma #LifeSciences #PatentCliff #Pharmaceuticals #MergersAndAcquisitions #PharmaLeadership

Check out our first article in a series of thought leadership all about the power of strategic partnerships in Pharma!

💊 Pharma's Next Big Challenge: The Patent Cliff! The pharmaceutical industry faces major shifts, with $183.5 billion in revenue at risk from patent expirations by 2030. Companies like Amgen, Bristol Myers Squibb, and Merck will be most affected, but with $383.1 billion in negotiation power, the industry is set to tackle these challenges! Follow us to see how top LCM strategies help the industry stay resilient 💪 Comment below 👇 for the original article. #PharmaTrends #PatentCliff #RevenueProtection #BigPharma #StrategicGrowth #Pharmaceuticals #Innovation #Biotech #FutureOfMedicine 

Why is it important for pharmaceutical organisations to strategically partner with each other and across the wider healthcare ecosystem? Through strategic partnerships, pharma organisation can leverage their strengths, share risks, and unlock innovation, resulting in benefits that far exceed the sum of the individual parts. Many organisations however grapple with how to effectively operate within a strategic partnership. Overcoming these challenges can lead to a range of benefits, from being perceived as an attractive innovative partner of choice, to navigating compliance in a more complex R&D setting, to achieving financial and scientific goals. Change the way your pharma organisation operates now to realise the potential of strategic partnerships and maximise health outcomes, both at an enterprise and partnership level. Find out more: https://ow.ly/O0PB50RvRGP #biotech #biopharma #pharma #lifesciences #pharmaceuticals #biotechnology Kate Moss (nee Watkins) Chris Maxted Samantha Sierwald Joshua Elliott

Pharma companies can unlock greater innovation and improve health outcomes by strategically partnering across the healthcare ecosystem. These partnerships leverage combined strengths and shared risks to tackle complex challenges, while also accelerating innovation through access to diverse expertise and resources.  This collaborative approach can transform your organization - learn more about the power of strategic partnerships https://ow.ly/O0PB50RvRGP